Tick disease research gets extended but with smaller budget
S. 2294 — Kay Hagan Tick Reauthorization Act · Filed by Susan Collins (R-ME) · 5 cosponsors · Introduced Jul 15, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill reauthorizes two federal tick-borne disease programs through 2030. It extends funding for a national strategy and regional centers of excellence in vector-borne disease research (reducing funding from $10M to $8M annually) and extends funding to help state health departments address vector-borne diseases (reducing funding from $20M to $19M annually). The bill also makes a technical correction to reference the correct statutory citation for the Tick-Borne Disease Working Group.
Why we flagged it
The bill extends two existing federal programs addressing tick-borne disease surveillance, research, and state capacity. It is a routine reauthorization with technical amendments and funding adjustments.
What the text implies
- Funding reductions occur during a period of rising tick-borne disease incidence (Lyme disease cases have increased significantly in recent years), potentially limiting research and prevention capacity at a critical moment.
- The shift from 2021–2025 to 2026–2030 creates a one-year gap (2025–2026) in explicit authorization; programs may operate under continuing resolution or require separate appropriation.
- Technical correction to the Tick-Borne Disease Working Group reference (from section 2062 of the 21st Century Cures Act to 42 U.S.C. § 284s) may affect the composition or governance of the working group if the cited provisions differ materially.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Citizens benefit from continued federal support for tick-borne disease research and state health department capacity, addressing a genuine public health need. However, the funding reductions ($2M and $1M annually, respectively) may constrain program scope and effectiveness during a period when tick-borne illnesses are increasing nationally.
Who stands to gain
- State and local health departments
- Academic medical centers and research institutions receiving regional center funding
- Public health agencies conducting vector-borne disease surveillance
Named in the bill
Public Health Service Act, 21st Century Cures Act, Tick-Borne Disease Working Group, National Institutes of Health (implied), State health departments, Centers for Disease Control and Prevention (implied)
Where it stands
5 cosponsors: 3 Democrats, 1 Independents, 1 Republicans.
- Jul 15, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- Jul 15, 2025 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions.”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 6 disclosure filings across 6 quarters, Jun 2025 to Sep 2026. Those filings disclosed $120,000 in lobbying spend. A filing names 1 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Susan Collins, the sponsor, reported $2,689,613 in PAC receipts in the 2026 cycle.
- Center for Lyme Action — $120,000 on 6 filings
Lobbying Disclosure Act filings through Oct 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (964 characters) on Nov 15, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,910 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2025 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Oct 20, 2026 · page rendered 2026-11-22.
“Tick disease research gets extended but with smaller budget” QuorumCivic. https://share.quorumcivic.app/bill/119/s2294 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.